These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24756928)

  • 1. Interpreting in vitro micronucleus positive results: simple biomarker matrix discriminates clastogens, aneugens, and misleading positive agents.
    Bryce SM; Bemis JC; Mereness JA; Spellman RA; Moss J; Dickinson D; Schuler MJ; Dertinger SD
    Environ Mol Mutagen; 2014 Aug; 55(7):542-55. PubMed ID: 24756928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro micronucleus assay with size-classified micronucleus counting to discriminate aneugens from clastogens.
    Hashimoto K; Nakajima Y; Matsumura S; Chatani F
    Toxicol In Vitro; 2010 Feb; 24(1):208-16. PubMed ID: 19747535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miniaturized flow cytometry-based CHO-K1 micronucleus assay discriminates aneugenic and clastogenic modes of action.
    Bryce SM; Avlasevich SL; Bemis JC; Dertinger SD
    Environ Mol Mutagen; 2011 May; 52(4):280-6. PubMed ID: 20872831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxic mode of action predictions from a multiplexed flow cytometric assay and a machine learning approach.
    Bryce SM; Bernacki DT; Bemis JC; Dertinger SD
    Environ Mol Mutagen; 2016 Apr; 57(3):171-89. PubMed ID: 26764165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategy.
    Dertinger SD; Kraynak AR; Wheeldon RP; Bernacki DT; Bryce SM; Hall N; Bemis JC; Galloway SM; Escobar PA; Johnson GE
    Environ Mol Mutagen; 2019 Jul; 60(6):513-533. PubMed ID: 30702769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay.
    Bryce SM; Bernacki DT; Bemis JC; Spellman RA; Engel ME; Schuler M; Lorge E; Heikkinen PT; Hemmann U; Thybaud V; Wilde S; Queisser N; Sutter A; Zeller A; Guérard M; Kirkland D; Dertinger SD
    Environ Mol Mutagen; 2017 Apr; 58(3):146-161. PubMed ID: 28370322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone markers identify the mode of action for compounds positive in the TK6 micronucleus assay.
    Cheung JR; Dickinson DA; Moss J; Schuler MJ; Spellman RA; Heard PL
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Jan; 777():7-16. PubMed ID: 25726170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementarity of phosphorylated histones H2AX and H3 quantification in different cell lines for genotoxicity screening.
    Khoury L; Zalko D; Audebert M
    Arch Toxicol; 2016 Aug; 90(8):1983-95. PubMed ID: 26404763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric 96-well microplate-based in vitro micronucleus assay with human TK6 cells: protocol optimization and transferability assessment.
    Bryce SM; Avlasevich SL; Bemis JC; Tate M; Walmsley RM; Saad F; Van Dijck K; De Boeck M; Van Goethem F; Lukamowicz-Rajska M; Elhajouji A; Dertinger SD
    Environ Mol Mutagen; 2013 Apr; 54(3):180-94. PubMed ID: 23447390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of in vitro genotoxicants using a novel multiplexed biomarker assay compared to the flow cytometric micronucleus test.
    Wilde S; Dambowsky M; Hempt C; Sutter A; Queisser N
    Environ Mol Mutagen; 2017 Dec; 58(9):662-677. PubMed ID: 28940655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of DNA damage response improve in vitro micronucleus assays by revealing genotoxic mode of action and reducing the occurrence of irrelevant positive results.
    Avlasevich S; Pellegrin T; Godse M; Bryce S; Bemis J; Bajorski P; Dertinger S
    Mutagenesis; 2021 Nov; 36(6):407-418. PubMed ID: 34718711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evaluation of a flow cytometric in vitro micronucleus assay in CHO-K1 cells: a reliable platform that detects micronuclei and discriminates apoptotic bodies.
    Shi J; Bezabhie R; Szkudlinska A
    Mutagenesis; 2010 Jan; 25(1):33-40. PubMed ID: 19843589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro micronucleus assay scored by flow cytometry provides a comprehensive evaluation of cytogenetic damage and cytotoxicity.
    Bryce SM; Bemis JC; Avlasevich SL; Dertinger SD
    Mutat Res; 2007 Jun; 630(1-2):78-91. PubMed ID: 17434794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of micronucleus induction and DNA damage biomarkers in TK6 and A375 cells using flow cytometry.
    Sun X; Spellman RA; Engel M; Rubitski E; Schuler M
    Environ Mol Mutagen; 2024; 65(1-2):25-46. PubMed ID: 38333939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γH2AX and p53 responses in TK6 cells discriminate promutagens and nongenotoxicants in the presence of rat liver S9.
    Bernacki DT; Bryce SM; Bemis JC; Kirkland D; Dertinger SD
    Environ Mol Mutagen; 2016 Aug; 57(7):546-558. PubMed ID: 27364561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronuclei induced by aneugens and clastogens in mononucleate and binucleate cells using the cytokinesis block assay.
    Rosefort C; Fauth E; Zankl H
    Mutagenesis; 2004 Jul; 19(4):277-84. PubMed ID: 15215326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro micronucleus scoring by flow cytometry: differential staining of micronuclei versus apoptotic and necrotic chromatin enhances assay reliability.
    Avlasevich SL; Bryce SM; Cairns SE; Dertinger SD
    Environ Mol Mutagen; 2006 Jan; 47(1):56-66. PubMed ID: 16180205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The automated micronucleus assay for early assessment of genotoxicity in drug discovery.
    Tilmant K; Gerets HH; De Ron P; Cossu-Leguille C; Vasseur P; Dhalluin S; Atienzar FA
    Mutat Res; 2013 Feb; 751(1):1-11. PubMed ID: 23159395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interlaboratory evaluation of a flow cytometric, high content in vitro micronucleus assay.
    Bryce SM; Avlasevich SL; Bemis JC; Lukamowicz M; Elhajouji A; Van Goethem F; De Boeck M; Beerens D; Aerts H; Van Gompel J; Collins JE; Ellis PC; White AT; Lynch AM; Dertinger SD
    Mutat Res; 2008 Feb; 650(2):181-95. PubMed ID: 18182318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test.
    Meintières S; Biola A; Pallardy M; Marzin D
    Environ Mol Mutagen; 2003; 41(1):14-27. PubMed ID: 12552588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.